Robuta

https://www.jnj.com/media-center/press-releases/johnson-johnson-therapy-nipocalimab-granted-u-s-fda-fast-track-designation-in-systemic-lupus-erythematosus-sle Johnson & Johnson therapy nipocalimab granted U.S. FDA Fast Track designation in systemic lupus... Mar 3, 2026 - Fast Track designation reflects the unmet need in this serious disease and enables the potential for an accelerated FDA review timeline The designation is... fast track designation https://www.newswire.ca/news-releases/clementia-pharmaceuticals-receives-fast-track-designation-for-palovarotene-for-treatment-of-fibrodysplasia-ossificans-progressiva-fop-522291831.html Clementia Pharmaceuticals Receives Fast Track Designation for Palovarotene for Treatment of... /CNW/ -- Clementia Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to palovarotene,... fast track designationclementiapharmaceuticalsreceivestreatment https://pharma.economictimes.indiatimes.com/news/regulatory-update/fda-fast-track-designation-for-zydus-usnoflast-a-breakthrough-in-als-treatment/121482671 FDA Fast Track Designation for Zydus' Usnoflast: A Breakthrough in ALS Treatment, ETPharma Zydus Lifesciences secures FDA Fast Track designation for Usnoflast, its innovative treatment for amyotrophic lateral sclerosis (ALS), highlighting the urgency... fast track designation https://www.businesswire.com/news/home/20200514005854/en/Neuraptive-Therapeutics-Announces-FDA-has-Granted-Fast-Track-Designation-to-NTX-001-Clinical-Development-Program-for-Treatment-of-Patients-with-Peripheral-Nerve-Injuries Neuraptive Therapeutics Announces FDA has Granted Fast Track Designation to NTX-001 Clinical... Company has received fast track designation for it's lead product fast track designation https://markets.businessinsider.com/news/stocks/johnson-johnson-says-fda-grants-fast-track-designation-to-nipocalimab-1034489516 Johnson & Johnson says FDA grants Fast Track designation to nipocalimab | Markets Insider fast track designationjohnsonsaysfdagrants https://www.globenewswire.com/news-release/2025/05/01/3072233/0/en/FDA-Grants-OKYO-Pharma-Fast-Track-Designation-to-Urcosimod-for-Neuropathic-Corneal-Pain.html FDA Grants OKYO Pharma Fast Track Designation to Urcosimod LONDON and NEW YORK, May 01, 2025 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), an ophthalmology-focused bio-pharmaceutical company which is... fast track designationfdagrantsokyopharma https://www.businesswire.com/news/home/20240715129278/en/Diakonos-Oncology-Receives-FDA-Fast-Track-Designation-for-Pancreatic-Cancer-Dendritic-Cell-Vaccine-Names-Daniel-D.-Von-Hoff-M.D.-to-Scientific-Advisory-Board Diakonos Oncology Receives FDA Fast Track Designation for Pancreatic Cancer Dendritic Cell Vaccine;... Diakonos given FDA Fast Track Designation for Pancreatic Cancer Dendritic Cell Vaccine; Names Daniel D. Von Hoff, M.D. to Scientific Advisory Board fast track designation https://www.globenewswire.com/de/news-release/2025/04/29/3070088/0/en/incyclix-bio-granted-u-s-fda-fast-track-designation-for-inx-315-to-treat-ccne1-amplified-platinum-resistant-refractory-ovarian-cancer.html Incyclix Bio Granted U.S. FDA Fast Track Designation for Fast Track designation highlights potential of INX-315 to address unmet need for patients with recurrent advanced/metastatic cancer... fast track designationbiograntedufda https://health.economictimes.indiatimes.com/tag/fast+track+designation Fast track designation - Latest fast track designation , Information & Updates - Health -ET... ETHealthworld.com brings latest fast track designation news, views and updates from all top sources for the Indian Health industry. fast track designationlatest informationupdateshealthet https://www.businesswire.com/news/home/20201001005382/en/Pfizer-Receives-FDA-Fast-Track-Designation-for-Duchenne-Muscular-Dystrophy-Investigational-Gene-Therapy Pfizer Receives FDA Fast Track Designation for Duchenne Muscular Dystrophy Investigational Gene... Pfizer Inc. (NYSE: PFE) today announced that its investigational gene therapy candidate (PF-06939926) being developed to treat Duchenne muscular dystrophy (D... fast track designationduchenne muscular dystrophy https://www.prnewswire.com/news-releases/dynacure-receives-fast-track-designation-for-dyn101-an-investigational-antisense-oligonucleotide-for-the-treatment-of-myotubular-and-centronuclear-myopathies-301455840.html Dynacure Receives Fast Track Designation for DYN101, an Investigational Antisense Oligonucleotide... /PRNewswire/ -- Dynacure, a clinical stage biotechnology company focusing on Myotubular and Centronuclear Myopathies (CNM), a group of rare, debilitating,... fast track designationreceives https://www.prnewswire.com/news-releases/evofem-biosciences-receives-fast-track-designation-for-amphora-for-prevention-of-chlamydia-300601610.html Evofem Biosciences Receives Fast Track Designation for Amphora for Prevention of Chlamydia /PRNewswire/ -- Evofem Biosciences, Inc., (NASDAQ: EVFM) ("Evofem" or the "Company"), a biotechnology company developing innovative products to fill women's... fast track designationbiosciencesreceives https://www.businesswire.com/news/home/20210310005708/nl Vertex kondigt FDA Fast Track Designation aan en start van een Fase 1/2 klinische studie voor... Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) heeft vandaag aangekondigd dat de Amerikaanse Food en Drug Administration (FDA) Fast Track Designation voo... https://www.businesswire.com/news/home/20250519241527/en/Zai-Lab-Receives-U.S.-FDA-Fast-Track-Designation-for-ZL-1310-a-DLL3-Targeted-Antibody-Drug-Conjugate-for-Treatment-of-Extensive-Stage-Small-Cell-Lung-Cancer Zai Lab Receives U.S. FDA Fast Track Designation for ZL-1310, a DLL3-Targeted Antibody-Drug... Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to ZL-1310, the Com... https://www.businesswire.com/news/home/20220427006000/en/SQZ-Biotechnologies-Receives-FDA-Fast-Track-Designation-for-its-Lead-Cell-Therapy-Candidate-for-the-Treatment-of-HPV16-Tumors SQZ Biotechnologies Receives FDA Fast Track Designation for its Lead Cell Therapy Candidate for the... SQZ Biotechnologies (NYSE: SQZ), focused on unlocking the full potential of cell therapies for multiple therapeutic areas, today announced that the U.S. Food...